eDoc Telemed

We also understand the importance of building your own care team and making your records available, securely, to everyone on that team. We created eDoc so both sides can manage patient care the way it was meant to be done.

EWING, N.J. (PRWEB)
May 04, 2020

Emgenex, a physician-backed organization with a decade of experience in the healthcare technology field, has launched their new eDoc virtual care platform for patients and doctors. eDoc Telemed by Emgenex connects patients and doctors directly, without a complex healthcare system standing between them. The eDoc platform recruits board certified physicians from a variety of specialties and allows them to set their own fees for service without the complexities of insurance billing and the overhead costs of a large corporate medical system, lowering the costs for the patient and improving their access to rapid and convenient care.

eDoc providers are available at any time for both pre-scheduled and instant on-demand visits. Unlike other telemedicine platforms eDoc allows patients to choose the doctor that is best for them, have a one-on-one relationship with that doctor, and experience a concierge medicine approach without the membership fees and high costs of a traditional concierge practice.

“We are extremely excited to launch our new eDoc platform,” said Binoy Cherian, CEO of Emgenex. “Whether it is during normal scheduling or in a time of crisis, we understand just how important it is for patients to connect with their doctors when they need them. We also understand the importance of building your own care team and making your records available, securely, to everyone on that team. We created eDoc so both sides can manage patient care the way it was meant to be done,” said Cherian.

Doctors on the eDoc platform come from all around the United States, are licensed to practice in various states, most are board certified in their specialty, and they have been practicing medicine for years prior to joining the eDoc app. They are available for urgent care visits, mental health concerns, and the care of chronic conditions such as asthma, diabetes, and high blood pressure. The eDoc platform is accessible anytime, anywhere and patients can choose the specific doctors they want providing their care. The tools in the eDoc platform allow for clear communication by video, audio, and text. These tools are easy to use and designed to fade into the background so that patients can experience clear and effective communication that is true to the goal of the eDoc platform, a more direct connection between the patient and their doctor.

Convenience and security have been the foundation of all Emgenex products and eDoc is no different. HIPAA compliant encryption protects all communication on the platform. All patient medical documents are contained within the platform and can be accessed by a patient’s healthcare team without transferring records between doctor’s offices. All documentation from a visit is accessible to the patient so remembering what was discussed in a visit is no longer necessary. And conveniently, electronic prescriptions can be sent directly to a patient’s pharmacy of choice, available for pickup as soon as the visit is completed.

eDoc was created by Emgenex, a medical technology company with experience providing telehealth services to hospitals and clinics, as a way to provide a more personalized telemedicine experience by connecting doctors and patients directly. The eDoc platform gives patients more control over their care making healthcare more accessible and affordable by eliminating many of the middlemen present in other telemedicine platforms and health care systems. By choosing their own doctor and having access to that doctor without middlemen increasing the cost of care, eDoc patients enjoy improved access to healthcare in a time where the risks of leaving home to seek care in person are greater than ever.

eDoc app is available on web at http://www.edoctelemed.com, iOS and Android mobile apps are downloadable from Apple AppStore and Google Play Store.

About Emgenex: We are an international healthcare company that is focused around using technology to improve the healthcare experience for both patients and providers. We build cutting edge healthcare technology and make it accessible to providers by building intuitive user interfaces, AI driven analytics, and beautiful data visualization tools for point-of-care decision support. Through the use of genomics to drive personalized medicine approaches, we can decrease the time to develop medical insight, improve accuracy of diagnosing and reduce errors. Learn more about Emgenex at http://www.emgenex.com.

Share article on social media or email:

This survey demonstrates that while EHR companies claim to provide comprehensive analytics to their customers, hospitals and health systems feel these tools are lacking in functionality.

BURLINGTON, Mass. (PRWEB)
May 04, 2020

Dimensional Insight®, maker of Diver® Platform, the 2020 Best in KLAS healthcare business intelligence and analytics solution, today announced the results of a Definitive Healthcare survey on EHR analytics that it sponsored. The survey found that EHR analytics yields lower user satisfaction than both analytics-specific platforms and in-house solutions. Users feel most frustrated with the speed of EHR analytics solutions, the lack of robustness, and the lack of interoperability.

Definitive Healthcare surveyed 108 healthcare leaders about their use of analytics solutions. Overall, 90% of healthcare organizations use the analytics in their EHR systems, with nearly 50% of organizations using EHR analytics exclusively or as their primary analytics tool. However, despite widespread use, satisfaction with EHR analytics is lower than satisfaction with both analytics-specific platforms and in-house solutions.

• 
  On a scale of 0-10 (0=extremely dissatisfied, 10=extremely satisfied) users of EHR analytics report an average satisfaction rating of 5.58.
• Users of in-house solutions report an average satisfaction of 6.51, and analytic-specific platform users report an average satisfaction of 6.69.

EHR analytics users frequently reported technology challenges with their solutions:

• 43.4% said reporting and querying of EHR analytics is slow.
• 35.8% said the component is not robust or advanced enough.
• 30.2% felt challenged with interoperability with other systems.
• 28.3% said EHR analytics lacks the visualization they need.
• 26.4% said the user interface is difficult to understand or use.

On the flip side, top challenges with analytics-specific platforms were interoperability with other systems (59.4%) and cost (40.6%). Both current users (6.85 on 0-10 scale) and non-users (7.40) of these platforms felt the solution could add value to their ability to perform analytics.

“This survey demonstrates that while EHR companies claim to provide comprehensive analytics to their customers, hospitals and health systems feel these tools are lacking in functionality,” says George Dealy, vice president of healthcare solutions at Dimensional Insight. “Analytics users find these tools slow, unadvanced, and not catered to their needs, while finding much greater satisfaction with analytics-specific platforms.”

Dimensional Insight and Definitive Healthcare will be holding a webinar to share more in-depth results from the survey.

    When: Tuesday, May 12, 2020

    Time: 2:00 p.m. ET / 1:00 p.m. CT / 12:00 p.m. MT / 11:00 a.m. PT

    Panelists: Brendan Fitzgerald, Senior Director of Research, Definitive Healthcare

    Kathy Sucich, Director of Healthcare Marketing, Dimensional Insight

    Register: https://attendee.gotowebinar.com/register/7152076155026844941

To learn more about the results of the survey, you can download a full report at: https://www.healthcare.dimins.com/resources/whitepapers/healthcare-organizations-ehr-analytics/

About Dimensional Insight

Dimensional Insight® is a leading provider of analytics, data management, and performance management solutions, offering a complete portfolio of capabilities ranging from data integration and modeling to sophisticated reporting, analytics, and dashboards. The company is a seven-time Best in KLAS winner in healthcare business intelligence and analytics, most recently ranking #1 in 2020. Founded in 1989, Dimensional Insight has thousands of customer organizations worldwide. Dimensional Insight consistently ranks as a top performing analytics organization by customers and industry analysts in its core market segments including healthcare, manufacturing, and beverage alcohol. For more information, please visit https://www.dimins.com/.

Share article on social media or email:

“We are pleased to recognize Dr. Carl Bischoff as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson

PLEASANTON, Calif. (PRWEB)
May 04, 2020

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Carl Bischoff, M.D., Austin Urology in Austin, TX, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Bischoff has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are pleased to recognize Dr. Carl Bischoff as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “This achievement has helped many patients experience durable, long term relief from the burdensome symptoms of BPH while preserving sexual function*1,2.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504 nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

CyberMaxx™ Listed as a Top Managed Security Service Provider (MSSP) To Watch in 2020 By Cybersecurity Ventures

CyberMaxx experts quickly become teammates that you know on a first-name basis.

NASHVILLE, Tenn. (PRWEB)
May 04, 2020

CyberMaxx™ is honored to be named a Top Managed Security Service Provider (MSSP) to Watch in 2020 by Cybersecurity Ventures’ CyberCrime Magazine.

“The global shortage of cybersecurity professionals is expected to reach 3.5 million unfilled positions by 2021. MSSPs are responding to the labor crunch by providing organizations of all types and sizes with a growing portfolio of services to choose from,” says Steve Morgan, Editor-In-Chief of CyberCrime Magazine.

With the onset of COVID-19, the need for cybersecurity expertise has never been greater. Remote work leaves organizations vulnerable to criminals testing networks and pushing PHISHING scams. Healthcare organizations need tailored, and scalable managed cybersecurity solutions to mitigate loss and gain peace of mind.

“What sets CyberMaxx apart from other MSSPs is our proven experience becoming our customer’s trusted partner, backed by an over 98% customer retention rate,” says Thomas Lewis, CEO and Co-Founder of CyberMaxx. “CyberMaxx experts quickly become teammates that you know on a first-name basis.”

With more than 15 years of experience, CyberMaxx prevents, detects, and responds to cyberattacks for healthcare organizations. CyberMaxx services include endpoint threat detection and response, network-based threat detection and prevention, security information and event management (SIEM) with advanced data analytics, vulnerability risk management, and incident response services.

Contact CyberMaxx for more information about healthcare cybersecurity solutions by visiting CyberMaxx.io.

Media Contact

Erin C. Kennedy | CyberMaxx | 615.309.2514 | ekennedy@cybermaxx.io

Share article on social media or email: